Cancer Pharmacology

Pharmacy

Queen's University Belfast

School of Pharmacy

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

My research focuses on improving treatment outcomes for women with ovarian cancer through functional precision pharmacology. We study drug behaviour across 2D, 3D, and immune cell co-culture models to evaluate systems-level responses to treatment. In parallel, we are developing high-throughput drug screening assays using patient-derived samples to assess tumour sensitivity to standard and repurposed agents, including identification of novel combination therapies. This work aims to drive innovation in guiding therapy selection in ovarian cancer.

  • Dr Fiona Furlong: School of Pharmacy

Contact info

  • View Academic Profile
  • f.furlong@qub.ac.uk
  • 02890 9097 0000

Research Interests

Open to PhD applications in the field of

Make a PhD enquiry

  • Cancer Pharmacology
  • Precision Medicine
  • Translational Oncology
  • Drug Repurposing/Experimental Therapies
  • High Content Screening
  • Cancer Cell Biology

Public outreach & key achievements

  • Irish Cancer Society Research Fellow
  • https://igcs.org/wp-content/uploads/2024/09/Advocacy-Poster-Booklet-2024Final.pdf

Research students

PhD Title | Evaluation of immunogenic cell death in ovarian cancer

Name | Mr Benjamin Pepperrell

Country | UK

Years of Study | 2023 - 2027

PhD Title | An investigation of novel interacting drug combinations in the treatment of ovarian cancer

Name | Dr Yu Sun

Country | China

Years of Study | 2022 - 2026

PhD Title | Investigation of the pathophysiological role of HDAC6 in triple negative breast cancer

Name | Dr Leen Asaad

Country | Jordan

Year of Study | 2021 - 2024

Alumni: Where are they now

PhD Title | Investigation of the pathophysiological role of HDAC6 in triple negative breast cancer

Name | Dr Leen Asaad

Years of Study | 2021 - 2024

Country | Jordan

Current Position | Assistant Professor in University of Petra, Jordan

PhD Title | The Evaluation of the effects of the Mitotic Arrest Deficiency Protein 2 (MAD2) and the miR-433 microRNA on Chemoresistance and Cancer Prognosis

Name | Dr Tara Byrne

Years of Study | 2013 - 2017

Country | Northern Ireland

Current Position | Clinical Supplies Manager at ICON

PhD Title | The contribution of the microRNA miR-433 to the pathology of ovarian cancer

Name | Dr Karolina Weiner-Gorzel

Years of Study | 2011 - 2014

Country | Poland

Current Position | Medical Oncology Registrar in St. Vincent’s University Hospital, Dublin, Ireland

Discover More

  • Faculty of Medicine, Health & Life Sciences
  • School of Pharmacy
  • Materials and Advanced Technologies for Healthcare
  • LinkedIn profile

Research areas

Cancer PharmacologyPrecision MedicinePharmacologyCell BiologyCell biologymedicineOncologyMedicine

Related PhD opportunities